Gregory A. Rener

714 total citations
20 papers, 596 citations indexed

About

Gregory A. Rener is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Gregory A. Rener has authored 20 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 8 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Gregory A. Rener's work include Synthesis and Characterization of Heterocyclic Compounds (5 papers), Synthesis and Biological Evaluation (5 papers) and Synthesis and biological activity (4 papers). Gregory A. Rener is often cited by papers focused on Synthesis and Characterization of Heterocyclic Compounds (5 papers), Synthesis and Biological Evaluation (5 papers) and Synthesis and biological activity (4 papers). Gregory A. Rener collaborates with scholars based in United States, France and Belgium. Gregory A. Rener's co-authors include Carroll Temple, C. JUN. TEMPLE, M. J. A. Simpson, George R. Pettit, Michael R. Boyd, V. L. Narayanan, Namita Bansal, Ravi K. Varma, Rob Comber and William R. Waud and has published in prestigious journals such as Biochemistry, Journal of Medicinal Chemistry and Journal of Chromatography A.

In The Last Decade

Gregory A. Rener

20 papers receiving 575 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory A. Rener United States 11 336 285 93 60 53 20 596
Marina Caldarelli Italy 13 283 0.8× 322 1.1× 95 1.0× 40 0.7× 30 0.6× 22 528
Anne Mengel Germany 12 623 1.9× 414 1.5× 88 0.9× 26 0.4× 58 1.1× 18 967
Thomas E. Barta United States 15 253 0.8× 319 1.1× 89 1.0× 48 0.8× 55 1.0× 25 649
Darin E. Jones United States 20 373 1.1× 297 1.0× 69 0.7× 38 0.6× 39 0.7× 44 796
Tsunehiko Soga Japan 16 420 1.3× 307 1.1× 207 2.2× 18 0.3× 46 0.9× 36 711
Hirosato Ebiike Japan 14 480 1.4× 605 2.1× 120 1.3× 28 0.5× 105 2.0× 31 1.0k
Laurent Ettouati France 11 311 0.9× 198 0.7× 124 1.3× 26 0.4× 108 2.0× 27 574
Mel C. Schroeder United States 10 350 1.0× 415 1.5× 60 0.6× 61 1.0× 63 1.2× 17 650
Edgar Voß Germany 13 206 0.6× 199 0.7× 43 0.5× 35 0.6× 21 0.4× 18 481
Kurt Eger Germany 18 532 1.6× 428 1.5× 84 0.9× 15 0.3× 69 1.3× 76 1.0k

Countries citing papers authored by Gregory A. Rener

Since Specialization
Citations

This map shows the geographic impact of Gregory A. Rener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory A. Rener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory A. Rener more than expected).

Fields of papers citing papers by Gregory A. Rener

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory A. Rener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory A. Rener. The network helps show where Gregory A. Rener may publish in the future.

Co-authorship network of co-authors of Gregory A. Rener

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory A. Rener. A scholar is included among the top collaborators of Gregory A. Rener based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory A. Rener. Gregory A. Rener is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kissane, Marie, Scott A. Frank, Gregory A. Rener, et al.. (2013). Counterion effects in the preparation of aldehyde–bisulfite adducts. Tetrahedron Letters. 54(48). 6587–6591. 17 indexed citations
3.
May, Scott A., Martin D. Johnson, Timothy M. Braden, et al.. (2012). Rapid Development and Scale-Up of a 1H-4-Substituted Imidazole Intermediate Enabled by Chemistry in Continuous Plug Flow Reactors. Organic Process Research & Development. 16(5). 982–1002. 46 indexed citations
4.
Jones, Timothy M., Robert J. Barbuch, David A. Jackson, et al.. (2011). Metabolism of LY654322, a Growth Hormone Secretagogue, to an Unusual Diimidazopyridine Metabolite. Drug Metabolism and Disposition. 39(5). 740–749. 1 indexed citations
5.
Kulanthaivel, Palaniappan, Robert J. Barbuch, Ping Yi, et al.. (2004). SELECTIVE REDUCTION OF N-OXIDES TO AMINES: APPLICATION TO DRUG METABOLISM. Drug Metabolism and Disposition. 32(9). 966–972. 48 indexed citations
6.
Kulanthaivel, Palaniappan, et al.. (2004). A method for the synthesis of 2‐amino‐4‐fluoro‐bicyclo[3.1.0]hexane‐2,6‐dicarboxylic acid‐[3H2]. Journal of Labelled Compounds and Radiopharmaceuticals. 47(9). 571–581. 3 indexed citations
7.
Barbier, Pascale, et al.. (1996). Kinetics of Association and Dissociation of Two Enantiomers, NSC 613863 (R)-(+) and NSC 613862 (S)-(−) (CI 980), to Tubulin. Biochemistry. 35(6). 2008–2015. 6 indexed citations
8.
Barbier, Pascale, Vincent Peyrot, M. Sarrazin, Gregory A. Rener, & Claudette Briand. (1995). Differential Effects of Ethyl 5-Amino-2-methyl-1,2-dihydro-3-phenylpyrido[3,4-b]pyrazin-7-yl Carbamate Analogs Modified at Position C2 on Tubulin Polymerization, Binding, and Conformational Changes. Biochemistry. 34(51). 16821–16829. 10 indexed citations
9.
Pettit, George R., C. JUN. TEMPLE, V. L. Narayanan, et al.. (1995). Antineoplastic agents 322. synthesis of combretastatin A-4 prodrugs.. PubMed. 10(4). 299–309. 199 indexed citations
10.
Elliott, Robert D., et al.. (1994). Phosphonate Analogs of Carbocyclic Nucleotides. Journal of Medicinal Chemistry. 37(6). 739–744. 20 indexed citations
11.
Inés, Concepción de, Isabel Barasoaı́n, Vincent Peyrot, et al.. (1994). Inhibition of microtubules and cell cycle arrest by a new 1-deaza-7,8-dihydropteridine antitumor drug, CI 980, and by its chiral isomer, NSC 613863.. PubMed. 54(1). 75–84. 60 indexed citations
12.
Peyrot, Vincent, M. Sarrazin, Claudette Briand, et al.. (1993). Tubulin binding of two 1-deaza-7,8-dihydropteridines with different biological properties: Enantiomers NSC 613862 (S)-(-) and NSC 613863 (R)-(+). Biochemistry. 32(40). 10675–10682. 16 indexed citations
13.
Temple, Carroll & Gregory A. Rener. (1992). Antimitotic agents. Chiral isomers of ethyl 5-amino-1,2-dihydro-3-(4-hydroxyphenyl)-2-methylpyrido[3,4-b]pyrazin-7-ylcarbamate. Journal of Medicinal Chemistry. 35(6). 988–993. 3 indexed citations
14.
Temple, Carroll, et al.. (1992). Antimitotic agents: structure-activity studies with some pyridine derivatives. Journal of Medicinal Chemistry. 35(20). 3686–3690. 59 indexed citations
15.
Temple, Carroll & Gregory A. Rener. (1992). Antimitotic agents: ring analogs and derivatives of ethyl [(S)-5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7-yl]carbamate. Journal of Medicinal Chemistry. 35(26). 4809–4812. 7 indexed citations
16.
Temple, Carroll, Gregory A. Rener, Rob Comber, & William R. Waud. (1991). Antimitotic agents. Alterations at the 2,3-positions of ethyl (5-amino-1,2-dihydropyrido[3,4-b]pyrazin-7-yl)carbamates. Journal of Medicinal Chemistry. 34(11). 3176–3181. 1 indexed citations
17.
TEMPLE, C. JUN. & Gregory A. Rener. (1990). Potential antimitotic agents. Synthesis of some ethyl benzopyrazin-7-ylcarbamates, ethyl pyrido[3,4-b]pyrazin-7-ylcarbamates, and ethyl pyrido[3,4-e]-as-triazin-7-ylcarbamates. Journal of Medicinal Chemistry. 33(11). 3044–3050. 3 indexed citations
18.
Temple, Carroll, Gregory A. Rener, & Rob Comber. (1989). New anticancer agents: alterations of the carbamate group of ethyl (5-amino-1,2-dihydro-3-phenylpyrido[3,4-b]pyrazin-7-yl)carbamates. Journal of Medicinal Chemistry. 32(10). 2363–2367. 15 indexed citations
19.
Temple, Carroll & Gregory A. Rener. (1989). New anticancer agents: chiral isomers of ethyl 5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazine-7-carbamate. Journal of Medicinal Chemistry. 32(9). 2089–2092. 24 indexed citations
20.
Temple, Carroll, Jerry D. Rose, Rob Comber, & Gregory A. Rener. (1987). Synthesis of potential anticancer agents: imidazo[4,5-c]pyridines and imidazo[4,5-b]pyridines. Journal of Medicinal Chemistry. 30(10). 1746–1751. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marina Caldarelli Breakdown of academic impact, for papers by Anne Mengel Breakdown of academic impact, for papers by Thomas E. Barta Breakdown of academic impact, for papers by Darin E. Jones Breakdown of academic impact, for papers by Tsunehiko Soga Breakdown of academic impact, for papers by Hirosato Ebiike Breakdown of academic impact, for papers by Laurent Ettouati Breakdown of academic impact, for papers by Mel C. Schroeder Breakdown of academic impact, for papers by Edgar Voß Breakdown of academic impact, for papers by Kurt Eger
Rankless by CCL
2026